[{"author":"PhilipEtienne","content":"Phenomenal presentation of @resapphealth at Blue Ventures - $RAP up  &gt;1000% in last year, but product road map going forward is impressive","pubdate":"20161007144053","NumFavorite":1,"NumShare":1,"CrawlerDate":20200720},{"author":"PhilipEtienne","content":"Deutsche creates new $50bn HF &amp; structured products arm  https:\/\/t.co\/zWdkHYhtLk this will go just incredibly well - nothing to see here $DB","pubdate":"20161007153251","NumFavorite":5,"NumShare":2,"CrawlerDate":20200720},{"author":"BrattleStCap","content":"RT @srussolillo: The ETF with a 0.00% fee: \u201cA negative management fee is certainly conceivable.\u201d https:\/\/t.co\/AtFglImySj via @jasonzweigwsj\u2026","pubdate":"20161007154703","NumFavorite":0,"NumShare":13,"CrawlerDate":20200720},{"author":"UnderwaterCap","content":"@retardedbearcap @NeckarValue No it's good point. Auditor is Deloitte. Company spent 10 mm for audit in 2015 when it also IPOed.","pubdate":"20161007161154","NumFavorite":2,"NumShare":0,"CrawlerDate":20200720},{"author":"UnderwaterCap","content":"@retardedbearcap @NeckarValue Granted Deloitte had stepped in poop before so not 100% , but 2 star strategic involvement here = good comfort","pubdate":"20161007161426","NumFavorite":0,"NumShare":0,"CrawlerDate":20200720}]